The polymorphism Arg585Gln in the gene of the sterol regulatory element binding protein-1 (SREBP-1) is not a determinant of ketosis prone type 2 diabetes (KPD) in Africans

Diabetes and Metabolism

Volumn 35, Issue 1, 2009, Pages 20-24

  Choukem, S P ^a   Boudou, P ^a   Sobngwi, E ^a,b   Villette, J M ^a   Ibrahim, F ^a   Moulin, P ^c   Hadjadj, S ^d   Eberle, D ^e   Foufelle, F ^e   Vexiau, P ^a   Gautier, J F ^a,e  

^a SAINT LOUIS HOSPITAL   (France)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c LOUIS PRADEL HOSPITAL   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Arg585Gln; G6PD; Insulin secretion; Ketosis prone type 2 diabetes; SREBF 1

Indexed keywords

ARGININE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN RELEASE; KETOSIS PRONE NON INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AMINO ACID SUBSTITUTION; ARGININE; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMINE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 60649086923     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.06.003     Document Type: Article

References (25)

1. Mauvais-Jarvis F., Sobngwi E., Porcher R., Riveline J.P., Kevorkian J.P., Vaisse C., et al. Ketosis prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta cell dysfunction and insulin resistance. Diabetes 53 (2004) 645-653
2. Sobngwi E., Vexiau P., Levy V., Lepage V., Mauvais-Jarvis F., Leblanc H., et al. Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 19 (2002) 832-835
3. Umpierrez G.E., Casals M.M., Gebhart S.P., Mixon P.S., Clark W.S., and Phillips L.S. Diabetic ketoacidosis in obese African-Americans. Diabetes 44 (1995) 790-795
4. Alberti K., and Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
5. Sobngwi E., Mauvais-Jarvis F., Vexiau P., Mbanya J.C., and Gautier J.F. Diabetes in Africans. Part 2: ketosis prone atypical diabetes mellitus. Diabetes Metab 28 (2002) 5-12
6. Umpierrez G.E., Smiley D., and Kitabchi A.E. Narrative review: ketosis prone type 2 diabetes mellitus. Ann Intern Med 144 (2006) 350-357
7. Maldonado M.R., Otiniano M.E., Cheema F., Rodriguez L., and Balasubramanyam A. Factors associated with insulin discontinuation in subjects with ketosis prone diabetes but preserved beta cell function. Diabet Med 22 (2005) 1744-1750
8. Banerji M.A., Chaiken R.L., Huey H., Tuomi T., Norin A.J., Mackay I.R., et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 43 (1994) 741-745
9. Winter W.E., Maclaren N.K., Riley W.J., Clarke D.W., Kappy M.S., and Spillar R.P. Maturity onset diabetes of youth in black Americans. N Engl J Med 316 (1987) 285-291
10. Poitout V., and Robertson R.P. Minireview. Secondary beta cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143 (2002) 339-342
11. Sobngwi E., Gautier J.F., Kevorkian J.P., Villette J.M., Riveline J.P., Zhang S., et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis prone diabetes. J Clin Endocrinol Metab 90 (2005) 4446-4451
12. Foufelle F., and Ferré P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 366 (2002) 377-391
13. Horton J.D., Goldstein J.L., and Brown M.S. SREBP: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 (2002) 1125-1131
14. Hua X., Wu J., Goldstein J.L., Brown M.S., and Hobbs H.H. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF-1) and localisation of SREBF-1 and SREBF-2 to chromosomes 17p11.2 and 22q13. Genomics 25 (1995) 667-673
15. Ono H., Shimano H., Katagiri H., Yahagi N., Sakoda H., Onishi Y., et al. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52 (2003) 2905-2913
16. Shimomura I., Shimano H., Korn B.S., Bashmakov Y., and Horton J.D. Nuclear sterol regulatory element binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273 (1998) 35299-35306
17. Eberlé D., Clément K., Meyre D., Sahbatou M., Vaxillaire M., Le Gall A., et al. SREBF-1 polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 53 (2004) 2153-2157
18. Felder T.K., Oberkofler H., Weitgasser R., Mackevics V., Krempler F., Paulweber B., et al. The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int J Obes (Lond) 31 (2007) 1099-1103
19. Gautier J.F., Mourier A., de Kerviler E., Tarentola A., Bigard A.X., Villette J.M., et al. Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: relationship to insulin resistance. J Clin Endocrinol Metab 83 (1998) 1306-1311
20. Umpierrez G.E., Woo W., Hagopian W.A., Isaacs S.D., Palmer J.P., Gaur L.K., et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 22 (1999) 1517-1523
21. Linfoot P., Bergstrom C., and Ipp E. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus. Diabet Med 22 (2005) 1414-1419
22. Mauvais-Jarvis F., Smith S.B., Le May C., Leal S.M., Gautier J.F., Molokhia M., et al. PAX4 gene variations predispose to ketosis prone diabetes. Hum Mol Genet 13 (2004) 3151-3159
23. Mauvais-Jarvis F., Boudou P., Sobngwi E., Riveline J.P., Kevorkian J.P., Villette J.M., et al. The polymorphism Gly574Ser in the transcription factor HNF-1-alpha is not a marker of adult-onset ketosis prone atypical diabetes in Afro-Caribbean patients. Diabetologia 46 (2003) 728-729
24. Boutin P., Gresh L., Cisse A., Hara M., Bell G., Babu S., et al. Missense mutation Gly574Ser in the transcription factor HNF-1-alpha is a marker of atypical diabetes mellitus in African-American children. Diabetologia 42 (1999) 380-381
25. Amemiya-Kudo M., Shimano H., Hasty A.H., Yahagi N., Yoshikawa T., Matsuzaka T., et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 43 (2002) 1220-1235